Applying CRISPR/Cas13 to Construct Exosomal PD‐L1 Ultrasensitive Biosensors for Dynamic Monitoring of Tumor Progression in Immunotherapy-Reference-Cited by-同舟云学术

Applying CRISPR/Cas13 to Construct Exosomal PD‐L1 Ultrasensitive Biosensors for Dynamic Monitoring of Tumor Progression in Immunotherapy

Published:2020-07-20 Issue:10 Volume:3 Page:2000093
ISSN:2366-3987
Container-title:Advanced Therapeutics
language:en
Short-container-title:Adv. Therap.

Author:

He Yi¹²,Wu Yetao²,Wang Yu¹²,Wang Xueping¹,Xing Shan¹,Li Huilan¹,Guo Songhe³,Yu Xiaohui²,Dai Shuqin¹²,Zhang Ge³,Zeng Musheng¹²,Liu Wanli¹²^ORCID

Affiliation:

1. Department of Clinical Laboratory Medicine State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University cancer center 651 Dongfeng Road East, Yuexiu District Guangzhou 510080 P. R. China

2. State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center 651 Dongfeng Road East, Yuexiu District Guangzhou 510080 P. R. China

3. School of Pharmaceutical Sciences Sun Yat‐sen University No.132 Waihuandong Road, University Town Guangzhou 510006 P. R. China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology (medical),Biochemistry, medical,Genetics(clinical),Pharmaceutical Science,Pharmacology,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adtp.202000093

Reference38 articles.

1. Cancer-derived extracellular vesicles: friend and foe of tumour immunosurveillance

2. Exosomes: composition, biogenesis and function